About FDA
-
Division of Pharmaceutical Analysis
1114 Market St. Room 1002
St. Louis, Missouri 63101
Phone: (314) 539-2135 Fax: (314) 539-2113
Lucinda Buhse, Ph.D., Director
Benjamin Westenberger, Deputy Director
- Research Programs
- FDA-Track FY2010 Completed Key Project: Rapid Screening of Pharmaceuticals (PDF - 21KB)
- Publications
- Hot Topics
- Analysis of crude heparin by 1H-NMR, capillary electrophoresis, and strong-anion-exchange-HPLC for contamination by over sulfated chondroitin sulfate, J. Pharm. Biomed. Anal. 51 (2010) 921-926. This HPLC method has a limit of detection for OSCS of less than 0.1%. Crude Heparin (PDF - 199 KB) Posted 3/26/2010
- Method for at-site detection of Diethylene Glycol/Ethylene Glycol Contamination: Simple, At-Site Detection of Diethylene Glycol/Ethylene Glycol Contamination of Glycerin and Glycerin-Based Raw Materials by Thin-Layer Chromatography [PDF] by Allen S. Kenyon
- Documents related to enhanced mechanical calibration of dissolution apparatus: Mechanical Qualification of Dissolution Apparatus. 1 and 2 (updated 6/1/2006)
These documents are posted as examples and should not be viewed as an endorsement for or exclusion of any manufacturer of dissolution or measuring equipment
-
-







